BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 9490553)

  • 21. [Efficacy of an ultrashort protocol in the eradication of Helicobacter pylori].
    González Carro P; Legaz Huidobro ML; Pérez Roldán F; Ruíz Carrillo F; Pedraza Martín C; Sáez Bravo JM
    Rev Esp Enferm Dig; 1998 Aug; 90(8):594-5. PubMed ID: 9780793
    [No Abstract]   [Full Text] [Related]  

  • 22. Can lansoprazole, amoxicillin, and clarithromycin combination still be used as a first-line therapy for eradication of helicobacter pylori?
    Güliter S; Keleş H; Ozkurt ZN; Cengiz DU; Kolukisa E
    Turk J Gastroenterol; 2005 Mar; 16(1):29-33. PubMed ID: 16252185
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Antihelicobacter effects of melatonin].
    Malinovskaia NK; Rapoport SI; Zhernakova NI; Rybnikova SN; Postnikova LI; Parkhomenko IE
    Klin Med (Mosk); 2007; 85(3):40-3. PubMed ID: 17523403
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Helicobacter heilmannii infection in a child after successful eradication of Helicobacter pylori: case report and review of literature.
    Kato S; Ozawa K; Sekine H; Ohyauchi M; Shimosegawa T; Minoura T; Iinuma K
    J Gastroenterol; 2005 Jan; 40(1):94-7. PubMed ID: 15692795
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Choice of anti-helicobacter treatment of gastroduodenal ulcer associated with helicobater pylori].
    Starostin BD
    Ter Arkh; 1999; 71(8):46-50. PubMed ID: 10515037
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Prognostic factors of efficacy of eradication therapy in patients with duodenal ulcer].
    Kozlova IV; Eliseev IuIu; Pakhomova AL; Khan SA
    Klin Med (Mosk); 2005; 83(7):52-5. PubMed ID: 16117427
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Evidence-based management of gastroduodenal ulcer].
    Rodríguez Téllez M; Herrerías Esteban JM; Carmona Soria I; Herrerías Gutiérrez JM
    An Med Interna; 1998 Oct; 15(10):548-53. PubMed ID: 9844233
    [No Abstract]   [Full Text] [Related]  

  • 28. [Modern policy of anti-helicobacter therapy of ulcer disease].
    Ryss ES
    Klin Med (Mosk); 1998; 76(10):7-11. PubMed ID: 9865008
    [No Abstract]   [Full Text] [Related]  

  • 29. [Continued gastric acid inhibitory therapy after Helicobacter eradication?].
    Mössner J
    Internist (Berl); 1997 Nov; 38(11):1105-7. PubMed ID: 9453962
    [No Abstract]   [Full Text] [Related]  

  • 30. [Should H. pylori infection in duodenal ulcer be confirmed before administering eradicating treatment?].
    Gisbert JP; Pajares JM
    Med Clin (Barc); 1999 Jul; 113(4):134-7. PubMed ID: 10472599
    [No Abstract]   [Full Text] [Related]  

  • 31. Effect of Helicobacter pylori eradication on ulcer recurrence after simple closure of perforated duodenal ulcer.
    El-Nakeeb A; Fikry A; Abd El-Hamed TM; Fouda el Y; El Awady S; Youssef T; Sherief D; Farid M
    Int J Surg; 2009 Apr; 7(2):126-9. PubMed ID: 19138577
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The evaluation of the gastroprotective effect of sucralfate in Helicobacter pylori-associated gastric ulcer].
    Pavlenko OA; Samoĭlova AV; Krivova NA; Zaeva OB
    Klin Med (Mosk); 2007; 85(10):65-7. PubMed ID: 18154186
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recurrence of Helicobacter pylori infection and duodenal ulcer relapse, following successful eradication in an urban east Asian population.
    Khor CJ; Fock KM; Ng TM; Teo EK; Sim CS; Tan AL; Ng A
    Singapore Med J; 2000 Aug; 41(8):382-6. PubMed ID: 11256345
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The long-term reinfection rate and the course of duodenal ulcer disease after eradication of Helicobacter pylori in a developing country.
    Rollan A; Giancaspero R; Fuster F; Acevedo C; Figueroa C; Hola K; Schulz M; Duarte I
    Am J Gastroenterol; 2000 Jan; 95(1):50-6. PubMed ID: 10638558
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Triple versus dual therapy for eradicating Helicobacter pylori and preventing ulcer recurrence: a randomized, double-blind, multicenter study of lansoprazole, clarithromycin, and/or amoxicillin in different dosing regimens.
    Schwartz H; Krause R; Sahba B; Haber M; Weissfeld A; Rose P; Siepman N; Freston J
    Am J Gastroenterol; 1998 Apr; 93(4):584-90. PubMed ID: 9576452
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Eradication of Helicobacter pylori reduces the rate of duodenal ulcer rebleeding: a long-term follow-up study.
    Macri G; Milani S; Surrenti E; Passaleva MT; Salvadori G; Surrenti C
    Am J Gastroenterol; 1998 Jun; 93(6):925-7. PubMed ID: 9647020
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Twice-daily, 10-day triple therapy with omeprazole, amoxicillin, and clarithromycin for Helicobacter pylori eradication in duodenal ulcer disease: results of three multicenter, double-blind, United States trials.
    Laine L; Suchower L; Frantz J; Connors A; Neil G
    Am J Gastroenterol; 1998 Nov; 93(11):2106-12. PubMed ID: 9820381
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Efficacy of the triple therapy in the eradication of H. pylori in peptic ulcer].
    Boixeda de Miquel D
    Rev Esp Enferm Dig; 1997 Dec; 89(12):875-7. PubMed ID: 9494374
    [No Abstract]   [Full Text] [Related]  

  • 39. [The pharmacodynamic and ulcer-healing action of modern anti-ulcer agents].
    Gorshkov VA; Petrutik AV
    Ter Arkh; 1994; 66(2):45-7. PubMed ID: 8160144
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Relapse of duodenal ulcers after successful eradication of Helicobacter pylori in gastric ulcer patients.
    Sou Y; Saita H; Takahashi Y; Yoshinaga T; Matsukawa Y; Sekikawa A; Nakazawa T; Shio S; Kohigashi K
    J Gastroenterol; 1999; 34 Suppl 11():84-90. PubMed ID: 10616773
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.